200 likes | 256 Views
Global Campaign Europe: Making it better, stronger and more strategic. Rebekah Webb, Coordinator Global Campaign for Microbicides. Welcome to PATH Ferney. Program for Appropriate Technology in Health (PATH)
E N D
Global Campaign Europe: Making it better, stronger and more strategic Rebekah Webb, Coordinator Global Campaign for Microbicides
Welcome to PATH Ferney • Program for Appropriate Technology in Health (PATH) • PATH’s mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviour • Administrative home for the Global Campaign
Strategy Meeting Goals: • To improve GCE advocacy and coordination • To share approaches, experiences and best practices • To discuss and strategise the future direction for GCE
Warm-Up Exercise What do you want to have achieved with respect to microbicides in 2 years’ time? What would make you smile?
Coordinating Advocating Supporting Mobilising Awareness raising/promoting Collaborating Alliance New effort Focal point Reminding people Motivating Sustaining Last year we asked: What is GC Europe? “Not really a campaign – more a policy + advocacy collaboration”
Overview of Microbicides State of Play • Huge progress in last 5 years • Multiple products in trials – two years from now, first efficacy results for 3 different strategies • Promising new strategies for design/delivery • Funding is increasing steadily • International recognition of the potential role for microbicides
Overview • Despite the hype, still a long way to go • Current trials may not show effectiveness • Estimated $280 million needed over 10 years to get a vaginal microbicide • Rectal will cost about two-thirds of this amount • Other research needs must be funded too (e.g. microbicides for positive women) • The field is not prepared yet for the next stage
QUIZ Q - Which European country is the largest donor to microbicides research? A – the United Kingdom ($14.5 million annually)
QUIZ Q - Which European country leads the world in terms of contribution to microbicides as a share of GDP? A – Ireland and the Netherlands
Trials • Six products in Phase 3/2B (vaginal endpoint) • Total of 14 products in clinical trials – some with more than one formulation • Over 20 others behind that (no funding to push them on or not good enough to take on?) • Rectal trials beginning
Priorities for the field • Broaden the pipeline • Ensure success in clinical research • Improve regulatory landscape • Allocate sufficient funding • Manage resources well • Create dedicated research programs
What is needed • Contract mechanisms between governments and small biotechs to boost early research • Increased private sector investment • EMEA - clear standards for evidence and data required
Regulatory issues • Tightrope between approving too quickly or too slowly • How can regulatory approaches anticipate and review data and still get products to people quickly
EU Member States Donors = NORWAYSWEDEN DENMARK N’LANDS IRELANDUK Targets = BELGIUM GERMANYFRANCE ITALY
Other pan-European models • EATG • IPPF-EN • IAVI European partners • AIDS Action Europe • EuroNGOs • European Women’s Lobby
Should we join other networks? • Financial constraints on what we can put in (no revenue from partners) • Need to get microbicides onto their agendas – easier at the table • Many of our partners are members of these networks • Will our partners feel that they don’t have to raise microbicides because we are now there?
European Working Group • Consisting of all the partners in Europe • Selected smaller group - elected or self-selecting? • Responsibilities: fundraising, strategy, advice, material creation and support to secretariat staff • TOR
Projects pending • Finnish Presidency Meeting (Nordpol, IPPF-EN?) • European tour of the exhibit (European Commission, EP, Interact, Cairde, AIDS Fonds, Nordpol, Kumulus, Sensoa) • Rectal microbicides advocacy (NFI, HIV Denmark?) • Positive Women Working Group • Comprehensive responses at UNGASS and IEPFPFD, WAD etc - all • Working Groups on target populations • NSWP collaboration (GCM) • EATG collaboration (GCM)